Breast Cancer Trial, Not Yet Recruiting NCT07663006 Sponsor: Dana-Farber Cancer Institute Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07663006
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

This trial has several different parts, and each part has its own eligibility criteria. People may be eligible for one or more parts depending on their situation.

For patients (interviews/surveys and intervention pilot):

  • People who have been diagnosed with breast or cervical cancer confirmed by a laboratory test
  • People who are currently receiving treatment at the Butaro Cancer Center of Excellence (BCCOE) during the study period
  • People aged 18 or older
  • People who are able to give their agreement to participate after being informed about the study
  • People who are able to take part in interviews or surveys in English or Kinyarwanda
  • For the intervention pilot specifically: people with confirmed breast cancer who are receiving chemotherapy before surgery, with clinic visits on a 3-week schedule, and who have at least 4 treatment cycles still remaining

For caregivers (interviews/surveys and intervention pilot):

  • People who are a caregiver — such as a spouse, child, family member, or other person chosen by the patient — of someone with confirmed breast or cervical cancer who is actively being treated at BCCOE
  • People aged 18 or older
  • People who are able to give their agreement to participate after being informed about the study
  • People who are able to take part in interviews or surveys in English or Kinyarwanda

For healthcare workers (focus groups and institutional surveys):

  • People who work as healthcare workers at a preselected health centre, district hospital, or provincial hospital in the Northern Province of Rwanda (for focus groups), or who are registered with a relevant professional healthcare organisation in Rwanda (for institutional surveys)
  • People aged 18 or older
  • People who are able to give their agreement to participate after being informed about the study
  • People who are able to take part in interviews or surveys in English or Kinyarwanda

For community health workers (intervention pilot):

  • People who are registered as community health workers with relevant healthcare facilities in Northern Rwanda
  • People aged 18 or older
  • People who are willing to take part in activities related to breast and cervical cancer and to support survivors
  • People who are able to give their agreement to participate after being informed about the study
  • People who are able to take part in pilot activities, interviews, or surveys in English or Kinyarwanda

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unwilling or unable to give their consent to take part in the study
  • People who are not able to understand the study language (English or Kinyarwanda)
  • People who are under 18 years of age, including infants, children, and teenagers
  • People who are currently in prison
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Temidayo Fadelu, MD, Dana-Farber Cancer Institute

Phone: +1 617-632-3779

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2026
Est. completion
1 December 2027

Where this trial is recruiting

Rwanda

Primary endpoints

Prevalence of Cancer Stigma; Change in Cancer-Related Stigma Score; Rate of Acceptability of Intervention Components; Rate of Appropriateness of Intervention Components; Rate of Feasibility of Intervention Components

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov